Literature DB >> 6466579

The oscillating 'vena cava syndrome' during quiet standing--an unexpected observation in late pregnancy.

K T Schneider, A Bollinger, A Huch, R Huch.   

Abstract

While studying the lung function of pregnant women at term in four different postures, we were surprised to note marked cyclic accelerations in the heart rate in two-thirds of the women when in a standing position. The mean cycle length was 105 s (range: 1-4 min) and the amplitude had a mean of 27 beats/min (range: 9-51). Blood flow velocity measurements with ultrasound Doppler over the femoral vein showed that there was an intermittent reduction of flow during quiet standing. When the venous return ceased, maternal heart rate increased, cardiac output decreased and blood pressure fell. After the venous blood flow was restored, maternal heart rate, cardiac output and blood pressure returned to normal until the cycle started again. Concomitant with these maternal heart rate changes, different patterns of fetal heart rate were observed. About 70% of the fetuses showed reduction in the long-term variability, increase in fetal heart rate or periodic accelerations. Although no woman fainted during quiet standing, the maternal circulatory changes were consistent with those seen in the classical vena cava syndrome.

Entities:  

Mesh:

Year:  1984        PMID: 6466579     DOI: 10.1111/j.1471-0528.1984.tb04847.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

Review 1.  Pregnancy complications of physicians.

Authors:  V L Katz; N H Miller; W A Bowes
Journal:  West J Med       Date:  1988-12

2.  [Travel in pregnancy].

Authors:  H Baumann
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

3.  [Pregnancy and professional activity].

Authors:  R Huch
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

Review 4.  Physical activity and pregnancy outcome. Review and recommendations.

Authors:  B Sternfeld
Journal:  Sports Med       Date:  1997-01       Impact factor: 11.928

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.